Stay updated on Anti-PD-1 Monoclonal Antibody Clinical Trial

Sign up to get notified when there's something new on the Anti-PD-1 Monoclonal Antibody Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anti-PD-1 Monoclonal Antibody Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The clinical trial record for tislelizumab in Chinese patients with advanced solid tumors is displayed, with study details, participant criteria, locations, and measured outcomes. The record also includes publications, history, and study documents.
    Difference
    53%
    Check dated 2026-11-08T13:56:13.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:14:33.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T14:07:15.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer shows revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-18T14:47:57.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The 403 Forbidden page remains unchanged in substance, with its footer revision label updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T13:57:57.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The clinical trial record page now displays a 403 Forbidden message, with a Home link, rather than study information.
    Difference
    0.5%
    Check dated 2026-10-04T15:41:56.000Z thumbnail image

Stay in the know with updates to Anti-PD-1 Monoclonal Antibody Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anti-PD-1 Monoclonal Antibody Clinical Trial page.